Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Wheeler

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Clinical Nuclear Medicine|February 1, 1991
In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomasM N Saleh, R H Wheeler, J Y Lee, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1997
Correlation of toxicity with treatment parameters for 131I-CC49 radioimmunotherapy in three phase II clinical trialsT Liu, R F Meredith, M N Saleh, et al.
American Journal of Clinical Oncology|December 1, 1992
A phase I study of high-dose cisplatin, prolonged infusion 5-fluorouracil, and concomitant conventional fraction radiation therapy in patients with inoperable squamous cell carcinoma of the head and neckM M Salter, R H Wheeler, G E Peters, et al.
American Journal of Clinical Oncology|February 20, 1999
Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neckS A Spencer, R H Wheeler, G E Peters, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Mouse/human chimeric monoclonal antibody in man: kinetics and immune responseA F LoBuglio, R H Wheeler, J Trang, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1991
A phase I study of prolonged infusion 5-fluorouracil and concomitant radiation therapy in patients with squamous cell cancer of the head and neckB Weppelmann, R H Wheeler, G E Peters, et al.
The Journal of Urology|July 1, 1994
Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomasR B Myers, R F Meredith, J Schlom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Clinical use of a standard kit-preparation of radiolabeled monoclonal antibody 96.5 in the diagnostic imaging of metastatic melanomaM N Saleh, D M Miller, L Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1992
Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancerR F Meredith, M B Khazaeli, T Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995
Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancerR F Meredith, M B Khazaeli, W E Plott, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Clinical Nuclear Medicine|February 1, 1991
In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomasM N Saleh, R H Wheeler, J Y Lee, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1997
Correlation of toxicity with treatment parameters for 131I-CC49 radioimmunotherapy in three phase II clinical trialsT Liu, R F Meredith, M N Saleh, et al.
American Journal of Clinical Oncology|December 1, 1992
A phase I study of high-dose cisplatin, prolonged infusion 5-fluorouracil, and concomitant conventional fraction radiation therapy in patients with inoperable squamous cell carcinoma of the head and neckM M Salter, R H Wheeler, G E Peters, et al.
American Journal of Clinical Oncology|February 20, 1999
Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neckS A Spencer, R H Wheeler, G E Peters, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Mouse/human chimeric monoclonal antibody in man: kinetics and immune responseA F LoBuglio, R H Wheeler, J Trang, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1991
A phase I study of prolonged infusion 5-fluorouracil and concomitant radiation therapy in patients with squamous cell cancer of the head and neckB Weppelmann, R H Wheeler, G E Peters, et al.
The Journal of Urology|July 1, 1994
Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomasR B Myers, R F Meredith, J Schlom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Clinical use of a standard kit-preparation of radiolabeled monoclonal antibody 96.5 in the diagnostic imaging of metastatic melanomaM N Saleh, D M Miller, L Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1992
Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancerR F Meredith, M B Khazaeli, T Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995
Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancerR F Meredith, M B Khazaeli, W E Plott, et al.
Pageof 8